Free. Unsubscribe any time.
Neumora Therapeutics, Inc. (NMRA)
Neumora Therapeutics, Inc. filed 7 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 7 transactions and 154,215 shares. 7 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-02-19, came 98 days after the one before it (2025-11-13) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 1,436 shares, 113,267 fewer than the 114,703 in the filing before it.
- Its 7 filings on file run from 2025-02-20 to 2026-02-19, and state 5 plan adoption dates, from 2024-04-18 to 2024-08-30.
Trades in Neumora Therapeutics, Inc. 7
- Aurora Daljit Singh — 2025-02-18 · S · 8,565 shares
- BERNS PAUL L — 2025-02-18 · S · 13,871 shares
- Lenz Robert A. — 2025-02-18 · S · 5,614 shares
- Milligan Michael Lee — 2025-02-18 · S · 1,978 shares
- Pinto Joshua — 2025-02-18 · S · 8,048 shares
- Aurora Daljit Singh — 2025-11-11 · S · 114,703 shares
- Milligan Michael Lee — 2026-02-17 · S · 1,436 shares
Adoption dates in Neumora Therapeutics, Inc. 5
- 2024-04-18 — stated in 1 filing
- 2024-04-19 — stated in 1 filing
- 2024-04-22 — stated in 2 filings
- 2024-06-12 — stated in 1 filing
- 2024-08-30 — stated in 2 filings
Results prints in Neumora Therapeutics, Inc. 0
Trades before a print in Neumora Therapeutics, Inc. 0
Interval to Neumora Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 7no later print
Adoption dates Neumora Therapeutics, Inc. states
- 2024-04-18 in 1 filing
- 2024-04-19 in 1 filing
- 2024-04-22 in 2 filings
- 2024-06-12 in 1 filing
- 2024-08-30 in 2 filings
Filing text: “10b5-1 trading plan, adopted on April 18, 2024”
Sources: SEC EDGAR full-text search and the SEC submissions API.